Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Frederik Wenz's publication output changed over time?
ScholarIQpublication output · 1994–2020
Output grew100% over the shown period — from 1 works in 1994 to 2 in 2020.
1
1
1
2
1
1
1
1
2
199420092010201220132015201620182020
What are the most-cited papers on Frederik Wenz?
ScholarIQmost cited works
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S. Vaidya, Frederik Wenz, Max Bulsara, Jeffrey Tobias, David Joseph, Mohammed Keshtgar, Henrik Flyger, Samuele Massarut, Michael Alvarado, Christobel Saunders, W. Eiermann, Marinos Metaxas, Elena Sperk, Marc Sütterlin, Douglas Brown, Laura J. Esserman, Mario Roncadin, Alastair M. Thompson, John Dewar, Helle Holtveg, Steffi Pigorsch, Mary Falzon, Eleanor Harris, April Matthews, Chris Brew‐Graves, Ingrid Potyka, Tammy Corica, Norman Williams, Michael Baum
The Lancet. 2013833 CitationsOPEN ACCESS
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
Jayant S. Vaidya, David Joseph, Jeffrey Tobias, Max Bulsara, Frederik Wenz, Christobel Saunders, Michael Alvarado, Henrik Flyger, Samuele Massarut, W. Eiermann, Mohammed Keshtgar, John Dewar, Uta Kraus-Tiefenbacher, Marc Sütterlin, Laura J. Esserman, Helle Holtveg, Mario Roncadin, Steffi Pigorsch, Marinos Metaxas, Mary Falzon, April Matthews, Tammy Corica, Norman Williams, Michael Baum
The Lancet. 2010766 CitationsOPEN ACCESS
Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.
K Rempp, Gunnar Brix, Frederik Wenz, Carl Becker, F. Gückel, Werner Lorenz
S50280174. 1994643 Citations
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post, Axel Matzdorff, Stephan Laechelt, Jörg T. Hartmann, Lothar Müller, Hartmut Link, Markus Moehler, E. Kettner, Elisabeth Fritz, U. Hieber, Hans Walter Lindemann, Martina Grunewald, Stephan Kremers, Christian Constantin, Matthias Hipp, G. Hartung, Deniz Gencer, Peter Kienle, Iris Burkholder, Andreas Hochhaus
The Lancet Oncology. 2012508 Citations
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
Patrick Maier, Linda Hartmann, Frederik Wenz, Carsten Herskind
International Journal of Molecular Sciences. 2016408 CitationsOPEN ACCESS
Related on ScholarIQ
University of Freiburg
Institution
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Paper
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
Paper
Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.
Paper
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Paper
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
Paper